<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16893</article-id><article-id pub-id-type="doi">10.25208/vdv16893</article-id><article-id pub-id-type="edn">wkvkdm</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL CASE REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>НАБЛЮДЕНИЕ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Development of amyloid lichen in a patient with atopic dermatitis</article-title><trans-title-group xml:lang="ru"><trans-title>Развитие амилоидного лихена у пациентки с атопическим дерматитом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4993-3269</contrib-id><contrib-id contrib-id-type="spin">7241-9483</contrib-id><name-alternatives><name xml:lang="en"><surname>Bitkina</surname><given-names>Oksana A.</given-names></name><name xml:lang="ru"><surname>Биткина</surname><given-names>Оксана Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>oksana381@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-2447-2719</contrib-id><contrib-id contrib-id-type="spin">9453-9271</contrib-id><name-alternatives><name xml:lang="en"><surname>Murashova</surname><given-names>Vera S.</given-names></name><name xml:lang="ru"><surname>Мурашова</surname><given-names>Вера Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>v.murashova2013@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Temnova</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Темнова</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>temnova1@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-2516-1529</contrib-id><contrib-id contrib-id-type="spin">9655-9614</contrib-id><name-alternatives><name xml:lang="en"><surname>Derpaluk</surname><given-names>Elena N.</given-names></name><name xml:lang="ru"><surname>Дерпалюк</surname><given-names>Елена Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>lena_derpaluk@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3175-0836</contrib-id><contrib-id contrib-id-type="spin">3543-2833</contrib-id><name-alternatives><name xml:lang="en"><surname>Bitkina</surname><given-names>Elizaveta V.</given-names></name><name xml:lang="ru"><surname>Биткина</surname><given-names>Елизавета Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>bitkinalisa@yandex.ru</email><xref ref-type="aff" rid="aff5"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Privolzhskiy Research Medical University</institution></aff><aff><institution xml:lang="ru">Приволжский исследовательский медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Lobachevsky State University of Nizhny Novgorod</institution></aff><aff><institution xml:lang="ru">Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Nizhegorodsky Regional Dermatovenereal Dispensary</institution></aff><aff><institution xml:lang="ru">Нижегородский областной кожно-венерологический диспансер</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Nizhny Novgorod Filial of State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Нижегородский филиал Государственного научного центра дерматовенерологии и косметологии</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">People Friendship University of Russia named after Patrice Lumumba</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов имени Патриса Лумумбы</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-02-06" publication-format="electronic"><day>06</day><month>02</month><year>2026</year></pub-date><volume>101</volume><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>110</fpage><lpage>117</lpage><history><date date-type="received" iso-8601-date="2025-04-18"><day>18</day><month>04</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-11-07"><day>07</day><month>11</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Bitkina O.A., Murashova V.S., Temnova I.V., Derpalyuk E.N., Bitkina E.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Биткина О.А., Мурашова В.С., Темнова И.В., Дерпалюк Е.Н., Биткина Е.В.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Bitkina O.A., Murashova V.S., Temnova I.V., Derpalyuk E.N., Bitkina E.V.</copyright-holder><copyright-holder xml:lang="ru">Биткина О.А., Мурашова В.С., Темнова И.В., Дерпалюк Е.Н., Биткина Е.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/16893">https://vestnikdv.ru/jour/article/view/16893</self-uri><abstract xml:lang="en"><p>The article considers a case of cutaneous amyloidosis that occurred in the setting of atopic dermatitis in a 32-year-old female patient. The patient has suffered from atopic dermatitis since the first months of her life, and homeopathic preparations have been used for treatment. Treatment with conventional medications and physiotherapy at the age of 20 years old resulted in a long-term remission, however, the patient noticed skin thickening in the areas of former rashes. Pathological examination of skin biopsy material and histochemical examination (hematoxylin and eosin, Van Gieson, toluidine blue, Congo red staining, PAS reaction) allowed to diagnose amyloid lichen. Amyloid lichen is a rare and severe complication of atopic dermatitis. Its incidence in patients with atopic dermatitis is approximately 0.8%. Contemporary methods of treating patients with atopic dermatitis accompanied by cutaneous amyloidosis are discussed. Topical products aimed at relieving inflammation and itching are used for initial treatment of amyloid lichen. Surgical treatments, as well as laser and phototherapy, may be used. Systemic medications (antihistamines, acitretin, cyclophosphamide and cyclosporine, upadacitinib, baricitinib) are an effective treatment option. Successful use of biological agents (dupilumab) has been reported.</p></abstract><trans-abstract xml:lang="ru"><p>Представлено описание 32-летней пациентки с атопическим дерматитом, на фоне которого развился амилоидоз кожи. Пациентка больна атопическим дерматитом с первых месяцев жизни, для лечения применялись гомеопатические препараты. В результате лечения, проведенного традиционными медикаментозными и физиотерапевтическими средствами в возрасте 20 лет, наступила длительная ремиссия, но пациентка обратила внимание на уплотнение кожи в участках бывших высыпаний. Использование патологоанатомического исследования биопсийного материала кожи и гистохимическое исследование (окраски гематоксилин-эозином, по Ван Гизону, толуидиновым синим, конго красным, ШИК-реакция) позволили установить диагноз амилоиднного лихена. Амилоидный лихен является редким и тяжелым осложнением атопического дерматита. Частота его встречаемости у пациентов с атопическим дерматитом составляет приблизительно 0,8%. Обсуждены современные методы терапии больных атопическим дерматитом, сопровождающимся амилоидозом кожи. Для начального лечения амилоидного лихена используются топические препараты, направленные на купирование воспаления и зуда. Возможно применение хирургических методов лечения, а также лазеро- и фототерапии. Эффективным способом лечения являются системные препараты (антигистаминные препараты, ацитретин, циклофосфамид и циклоспорин, упадацитиниб, барицитиниб). Сообщалось об успешном применении биологических препаратов (дупилумаб).</p></trans-abstract><kwd-group xml:lang="en"><kwd>skin amyloidosis</kwd><kwd>atopic dermatitis</kwd><kwd>histology</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>амилоидоз кожи</kwd><kwd>атопический дерматит</kwd><kwd>гистология</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Molina-Ruiz AM, Cerroni L, Kutzner H, Requena L. Cutaneous deposits. Am J Dermatopathol. 2014;36(1):1–48. doi: 10.1097/DAD.0b013e3182740122</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pepys MB. Amyloidosis. Annu Rev Med. 2006;57:223–241. doi: 10.1146/annurev.med.57.121304.131243</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Carretero M, Aguirre MA, Villanueva E, Nucifora E, Posadas-Martínez ML. Features and evolution of patients with systemic amyloidosis and cardiac involvement. Arch Cardiol Mex. 2022;92(1):60–67. doi: 10.24875/ACM.21000011</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol. 1997;37(6):923–928. doi: 10.1016/s0190-9622(97)70066-5</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kubanov AA, Karamova AE, Chikin VV, Znamenskaya LF, Kondrashova VV, Nefedova MA. Cutaneous lichen amyloidosis within scratched areas. Russian Open Medical Journal. 2018;7(2):e0205. doi: 10.15275/rusomj.2018.0205</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Денисова Е.В., Невозинская З.А., Плиева К.Т., Чепрасова А.В., Корсунская И.М. Редкие дерматологические патологии: амилоидоз кожи. Дерматология. Consilium Medicum. 2018;3:46–48. [Denisova EV, Nevozinskaya ZA, Plieva KT, Cheprasova AV, Korsunskaya IM. Rare dermatological diseases: amyloidosis of the skin. Dermatology (Suppl. Consilium Medicum). 2018;3:46–48. (In Russ.)] doi: 10.26442/2414-3537_2018.3.46-48</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Guillet C, Steinmann S, Maul JT, Colm I. Primary localized cutaneous amyloidosis: a retrospective study of an uncommon skin diseases in the tertiary care center in Switzerland. Dermatology. 2022;238(3):579–586. doi: 10.1159/00518948</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wisniowski B, Wechalekar A Confirming the Diagnosis of Amyloidosis. Acta Haematol. 2020;143(4):312–321. doi: 10.1159/000508022</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bély M. Histochemical differential diagnosis and polarization optical analysis of amyloid and amyloidosis. Scientific World Journal. 2006;6:154–168. doi: 10.1100/tsw.2006.35</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130(2–3):88–98. doi: 10.1006/jsbi.2000.4221</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Oh SM, Ahn HJ, Shin MK. Clinical characteristics of lichen amyloidosis associated with atopic dermatitis: A single center, retrospective study. Ann Dermatol. 2023;35(6):432–438. doi: 10.5021/ad.23.006</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Weidner T, Illing T, Elsner P. Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review. Am J Clin Dermatol. 2017;18(5):629–642. doi: 10.1007/s40257-017-0278-9</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Atacan D, Ergin C, Çelik G, Gönül M, Adabağ A. Oral isotretinoin: A new treatment alternative for generalized lichen amyloidosis. Australas J Dermatol. 2016;57(3):246–247. doi: 10.1111/ajd.12316</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Koh WS, Oh EH, Kim JE, Ro YS. Alitretinoin treatment of lichen amyloidosis. Dermatol Ther. 2017;30(6). doi: 10.1111/dth.12537</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Solimani F, Dilling A, Ghoreschi FC, Nast A, Ghoreschi K, Meier K. Upadacitinib for treatment-resistant Lichen amyloidosis. J Eur Acad Dermatol Venereol. 2023;37(5):e633–e635. doi: 10.1111/jdv.18756</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Xia D, Xiao Y, Li M, Li W. Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib. Dermatol Ther. 2022;35(9):e15724. doi: 10.1111/dth.15724</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Humeda Y, Beasley J, Calder K. Clinical resolution of generalized lichen amyloidosis with dupilumab: a new alternative therapy. Dermatology Online J. 2020;26(12):13030/qt64s0s466.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Zhao XQ, Zhu WJ, Mou Y, Xu M, Xia JX. Dupilumab for treatment of severe atopic dermatitis accompanied by lichenoid amyloidosis in adults: Two case reports. World J Clin Cases. 2023;11(10):2301–2307. doi: 10.12998/wjcc.v11.i10.2301</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases. 2023;11(11):2549–2558. doi: 10.12998/wjcc.v11.i11.2549</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Zahid S, Saussine A, Calugareanu A, Jachiet M, Vignon-Pennamen MD, Rybojad M. Dramatic response to dupilumab in papular amyloidosis. J Eur Acad Dermatol Venereol. 2022;36(12):e1071–e1072. doi: 10.1111/jdv.18482</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Tirone B, Cazzato G, Ambrogio F, Foti C, Bellino M. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option. Diseases. 2024;12(5):94. doi: 10.3390/diseases12050094</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Einstein D, Sarumathy G, Shobini Vishali VM, Prahhiba A, Perumal M, Sruthi P. Histopathological insights to primary localized cutaneous amiloidosis: a case series. 2025;17(2):e79603. doi: 10.7759/сureus.79603</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sabban ENC, Errichetti E, Cabo HA, Maronna E. Dermoscopy as a Supportive Tool to Differentiate Lichen Amyloidosus from Clinical Mimickers. Dermatol Pract Concept. 20221;12(3):e2022133. doi: 10.5826/dpc.1203a133</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Sonthalia S, Agrawal M, Sehgal VN. Dermoscopy of macular amyloidosis. Indian Dermatol Online J. 2020;12(1):203–205. doi: 10.4103/idoj.IDOJ_507_19</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Chatterjee M, Neema S. Dermoscopy of Pigmentary Disorders in Brown Skin. Dermatol Clin. 2018;36(4):473–485. doi: 10.1016/j.det.2018.05.014</mixed-citation></ref></ref-list></back></article>
